Regenerative Medicine & Cord Blood Stem Cells

Click For Info Kit

Regenerative medicine, relatively speaking, is in its infancy in terms of study and practice. But in less than a generation, it is already proving to be a powerful and promising science. For some families who have faced life-altering medical conditions, participation in “Regen Med” research with their banked cord blood was once-in-a-lifetime gift that cannot be measured.

What exactly is Regen Med?

Regenerative medicine is the science of living cells being used to potentially regenerate or facilitate the repair of cells damaged by disease, genetics, injury or simply aging.

Why cord blood stem cells? Think about it: the natural power and purity of your newborn's cord blood are responsible for healthy development during gestation. So it makes sense that they are the ones most likely to be called upon when studying ways in which science can help restore health.

Why Banking Matters Now

Research and trials led by scientific pioneers at world-renowned medical institutions are continually probing for new possibilities where the use of cord blood stem cells can make a difference in quality of life.


While studies show exciting promise - particularly in the areas of cerebral palsy111 and genetic brain diseases109 - we are still in early stages of discovery. But who knows what breakthroughs might come in the next 5...10...20 years? Having the foresight to bank now for the future health of your family is a powerful plan if regenerative therapies prove fruitful.110


For a quick summary of the the progress being made with clinical research studies for Autism and Cerebral Palsy, see our easy to read infographic.

Progress and Promise

Watch ViaCord's Chief Scientific Officer, Morey Kraus, discuss current therapies using cord blood and the progress of research being made on the regenerative medicine front.

Clinical Research Trials Happening Now

Clinical research trials in several areas of study are showing potential. ViaCord is proud to collaborate with leading medical experts and institutions to pursue answers that give families hope for a healthier future.

Improving Motor Function in Cerebral Palsy

A phase II trial at Duke University Medical Center evaluated the efficacy for pediatric patients using their own umbilical cord blood for the treatment of spastic cerebral palsy.

When patients were given an adequate dosage of their own stem cells, their Gross Motor Function Measure (GMFM-66) improved significantly.111

Unlocking the Mystery of Autism Spectrum Disorder (ASD)

ViaCord is proud to play a role in supporting an ongoing FDA-approved phase I clinical research trial at Duke University that involves infusing patients diagnosed with autistic spectrum disorder with their own cord blood stem cells.

This research is designed to better understand this complex disorder that affects so many families.

Premature Infant Studies

In the US, 500,000 newborns are born prematurely every year. Depending on how early, prematurity can present significant health complications for normal organ development and function.


A current study in partnership with Prentice Woman's Hospital aims to establish the feasibility of collecting cord blood and cord tissue from premature infants for potential medical use in conditions associated with premature birth. Samples in the study will be processed by ViaCord's Processing Laboratory and are available for future use by participating families under the direction of a physician.

Slowing the Advance in Juvenile Diabetes

A phase I study at the University of Florida funded by the National Institutes of Health and the Juvenile Diabetes Research Foundation was the first attempt to use cord blood stem cells as a treatment for the disease.

By infusing cord blood stem cells into the body, scientists hoped they could slow down the immune system's attack on pancreatic cells producing insulin and perhaps replace them.

Once the treatment was proven to be safe, a second phase of the study was launched.